Clinical trials
Terminated Pre-Eclampsia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 2 |
| Duke University | 2 |
| The University of Texas Medical Branch, Galveston | 2 |
| AMAG Pharmaceuticals, Inc. | 1 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Burak Yücel Special Clinic | 1 |
| Cairo University | 1 |
| Cedars-Sinai Medical Center | 1 |
| Christiana Care Health Services | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pre-Eclampsia | 40 |
| Hypertension, Pregnancy-Induced | 10 |
| Hypertension | 4 |
| Diabetes, Gestational | 2 |
| Eclampsia | 2 |
| Fetal Growth Retardation | 2 |
| Abortion, Spontaneous | 1 |
| Cognition Disorders | 1 |
| HELLP Syndrome | 1 |
| Hypertensive Crisis | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.